1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Typhoid Fever Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Typhoid Fever Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Typhoid Fever Vaccines Market Regional Analysis
6.2 Middle East and Africa Typhoid Fever Vaccines Market Revenue 2017-2027 (US$ Million)
6.3 Middle East and Africa Typhoid Fever Vaccines Market Forecast Analysis
7. Middle East and Africa Typhoid Fever Vaccines Market Analysis – by Vaccine Type
7.1 Live Attenuated Vaccine
- 7.1.1 Overview
- 7.1.2 Live Attenuated Vaccine: Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Capsular Polysaccharide Vaccines
- 7.2.1 Overview
- 7.2.2 Capsular Polysaccharide Vaccines: Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Conjugate Vaccine
- 7.3.1 Overview
- 7.3.2 Conjugate Vaccine: Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Middle East and Africa Typhoid Fever Vaccines Market Analysis – by Route of administration
8.1 Oral and Injectable
- 8.1.1 Overview
- 8.1.2 Oral and Injectable: Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Middle East and Africa Typhoid Fever Vaccines Market – Middle East and Africa Analysis
9.1 Overview
9.2 Middle East and Africa
- 9.2.1 Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.2.1.1 Middle East and Africa Typhoid Fever Vaccines Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 South Africa:
Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 South Africa: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.1.2 South Africa: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.2.1.2 Saudi Arabia:
Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Saudi Arabia: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.2.2 Saudi Arabia: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.2.1.3 UAE:
Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 UAE: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.3.2 UAE: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.2.1.4 Rest of Middle East and Africa:
Middle East and Africa Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Typhoid Fever Vaccines Market Breakdown, by Route of administration
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 GlaxoSmithKline plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Shanghai institute of biological products co. ltd.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sanofi
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pax Vax Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BHARAT BIOTECH
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations